On Jul. 8, 2021, access to the worldﾒs largest browsable resource linking rare protein-coding genetic variants to human health and disease was launched through a genetic exome sequence analysis collaboration between AbbVie, Biogen and Pfizer.

Managed by the Broad Institute of MIT and Harvard, the browser provided access to results from analyses of whole exome sequencing data from 300,000 UK Biobank research participants.